SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS
申请人:Zhi Lin
公开号:US20110003851A1
公开(公告)日:2011-01-06
The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity
作者:Cyrielle Billon、Sadichha Sitaula、Subhashis Banerjee、Ryan Welch、Bahaa Elgendy、Lamees Hegazy、Tae Gyu Oh、Melissa Kazantzis、Arindam Chatterjee、John Chrivia、Matthew E. Hayes、Weiyi Xu、Angelica Hamilton、Janice M. Huss、Lilei Zhang、John K. Walker、Michael Downes、Ronald M. Evans、Thomas P. Burris
DOI:10.1021/acschembio.2c00720
日期:——
type IIa oxidative skeletal muscle fibers and enhancedexercise endurance. We also observed that SLU-PP-332 induced an ERRα-specific acuteaerobicexercise genetic program, and the ERRα activation was critical for enhancingexercise endurance in mice. These data indicate the feasibility of targeting ERRα for the development of compounds that act as exercise mimetics that may be effective in the treatment